首頁
YEASEN BIOTECHNOLOGY

7月 2026YEASEN BIOTECHNOLOGY的市場佔有率分析

Our comprehensive range of core molecular biology reagents is designed to support a wide array of laboratory applications with precision and reliability. This collection includes high-performance real-time PCR reagents, standard Taq polymerase, high-fidelity enzymes, cloning reagents, and nucleic acid electrophoresis s

科學與教育 > 生物學

域名yeasenbio.com

成立年份2014

僱員1001 - 5000

年度營收--

YEASEN BIOTECHNOLOGY

YEASEN BIOTECHNOLOGY（包含公司地區）

yeasenbio.com

查看更多網站流量與參與度資訊

YEASEN BIOTECHNOLOGY的熱門網域總造訪量

了解YEASEN BIOTECHNOLOGY市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

yeasenbio.com78.3K

透過銷售情報查看更多內容

YEASEN BIOTECHNOLOGY的熱門網域平均造訪時長

分析YEASEN BIOTECHNOLOGY參與度指標。

過去 3 個月平均造訪時長

子公司細目

yeasenbio.com00:00:35

透過銷售情報查看更多內容

YEASEN BIOTECHNOLOGY的熱門網域平均頁面瀏覽量

了解YEASEN BIOTECHNOLOGY如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

yeasenbio.com1.73

透過銷售情報查看更多內容

YEASEN BIOTECHNOLOGY按網域劃分的熱門競爭對手

7月 2026的熱門類似網站，依相似度排名

thermofisher.com公司名Thermo Fisher Scientific僱員> 10001總部美國, 馬薩諸塞州, Waltham年度營收> $1B訪問總量6M健康 > 健康 - 其他

使用的熱門技術YEASEN BIOTECHNOLOGY

这些是YEASEN BIOTECHNOLOGY顶级域名使用的行业网站技术

付款與貨幣 (10)

Cart Functionality

付費廣告 (5)

DoubleClick

轉換與分析 (5)

Google Analytics

電子商務 (5)

Shopify

更多技術

12

檢視所有

新聞與訊號來自YEASEN BIOTECHNOLOGY

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Ebiohippo partners with Yeasen.At Biohippo, ELISA Kit Author: Biohippo Inc. partner with Yeasen Biotechnologies, a leading provider of molecular diagnostics products, to offer the research tools necessary for detecting DNA methylation.

新聞Yeasen launches variety of products.For DNA transfection reagents and RNA transfection reagents, Yeasen has a strong R&D and production team, continuously optimizes formulas, improves production processes, and has launched a variety of products based on cationic liposomes and cationic polymers.

新聞Yeasen expands facilities to Wuhan, China, Eastern Asia, Asia.To ensure product quality and production capacity, Yeasen has built a GMP-level production base in Wuhan to fully meet customers' industrial production needs, with an annual production capacity of more than 5 billion servings.